InChI=1S/C21H36N4O14/c1-8(2)38-19(20(35)36)25-13(30)5-23-18(34)10(24-12(29)4-22-9(3)27)7-37-21-16(33)14(31)15(32)17(39-21)11(28)6-26/h8,10-11,14-17,19,21,26,28,31-33H,4-7H2,1-3H3,(H,22,27)(H,23,34)(H,24,29)(H,25,30)(H,35,36)/t10-,11+,14-,15-,16-,17+,19-,21-/m0/s1 |
AWPWUSDAPCJRDC-TXOIZJTMSA-N |
[H][C@@]1(O[C@H](OC[C@H](NC(=O)CNC(C)=O)C(=O)NCC(=O)N[C@@H](OC(C)C)C(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O)[C@H](O)CO |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
View more via ChEBI Ontology
(2S,8S)-8-[({(2S,3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl}oxy)methyl]-2-isopropoxy-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic acid
|
(2S,8S)-8-[({(2S,3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl}oxy)methyl]-4,7,10,13-tetraoxo-2-[(propan-2-yl)oxy]-3,6,9,12-tetraazatetradecan-1-oic acid
|
IUPAC
|
AcGlySer(O-L-α-D-Hep)GlyLeu
|
ChEBI
|
N-acetylglycyl-L-seryl(O-L-glycero-α-D-manno-heptopyranosyl)glycyl-L-leucine
|
ChEBI
|
36542493
|
PubMed citation
|
Europe PMC
|
|